Kindred Biosciences, Inc. (KIN) Social Stream



Kindred Biosciences, Inc. (KIN): $9.25

0.01 (+0.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KIN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 508

in industry

Kindred Biosciences Inc (KIN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Kindred Biosciences Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $15.25 $9 $10.5 $9.25 13.51%

The Trend in the Analyst Price Target


KIN's average price target has moved down $0.39 over the prior 138 days.

Over the past 14 months, KIN's average upside potential has been 125.3%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-15 6 15.25 9 10.50 9.14 14.88%
2021-07-10 6 15.25 9 10.50 9.15 14.75%
2021-07-03 6 15.25 9 10.50 9.16 14.63%
2021-06-03 7 16.00 9 11.75 6.73 74.59%
2021-05-22 7 16.00 9 11.75 4.79 145.3%
2021-05-15 7 16.00 9 11.75 4.35 170.11%
2021-05-08 7 16.00 9 11.18 4.63 141.47%
2021-04-19 7 16.00 9 11.18 4.65 140.43%
2021-04-17 7 16.00 9 11.18 4.85 130.52%
2021-04-09 7 16.00 9 11.18 5.13 117.93%
2021-03-09 7 14.00 9 10.89 4.69 132.2%
2021-03-06 7 14.00 9 10.89 4.78 127.82%
2021-02-27 7 14.00 9 10.89 4.51 141.46%
2021-02-20 7 14.00 9 10.89 4.91 121.79%
2021-01-13 7 14.00 9 10.89 4.85 124.54%
2021-01-09 7 14.00 9 10.89 5.03 116.5%
2021-01-02 7 14.00 9 11.18 4.31 159.4%
2020-12-26 7 14.00 9 11.18 4.65 140.43%
2020-12-19 7 14.00 9 11.18 4.13 170.7%
2020-12-09 7 14.00 9 11.32 3.71 205.12%
2020-11-23 7 14.00 9 11.64 3.73 212.06%
2020-10-10 7 14.00 9 11.64 4.85 140%
2020-07-27 7 14.00 9 11.64 NA NA%
2020-07-22 7 25.00 9 13.64 NA NA%
2020-05-31 7 25.00 9 13.64 NA NA%

KIN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.71 1 2 4 0 0 7

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KIN as an investment opportunity.

  • The variance in analysts' estimates of KIN is lower than 17.29% of all US stocks.
  • KIN has a greater average analyst price target than 20.04% of all US stocks.
  • KIN has a higher upside potential (average analyst target price relative to current price) than 12.04% of Pharmaceutical Products stocks.
  • KIN has a higher number of analysts covering the stock than 79.02% of stocks in the small market cap category.

In the Pharmaceutical Products industry, IRWD, OGN and AMPH are the three stocks most similar to Kindred Biosciences Inc regarding the price target and analyst recommendation information presented here.

Is KIN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8144 seconds.